Zentalis Pharmaceuticals Llc (ZNTL)
Healthcare
Biotechnology
4.70 $
-1.9%
vs. previous close
Closing price · As of: 3. Aug 2026
Zentalis Pharmaceuticals Llc (ZNTL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -125 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| -24 | -39 | -87 | -154 | -164 | -208 | -171 | -125 | |
| 0.1 | 0.1 | 0.2 | 0.5 | 1.4 | 1.4 | 1.3 | 0.7 | |
| 0.3 | 0.6 | 23 | 36 | 47 | 55 | 67 | 21 | |
| 0.3 | -0.1 | 23 | 46 | 62 | – | – | – | |
| -1.2 | 6.5 | 7.8 | 17 | 13 | 5.9 | -17 | -9.1 | |
| 0.2 | 0.4 | 0.8 | 6.1 | 2.5 | 0.6 | 0.2 | 0.0 | |
| -0.2 | -0.4 | -285 | -18 | -114 | -44 | 177 | 132 | |
| 9.5 | 82 | 346 | 0.0 | 261 | 0.0 | 0.0 | -10.0 | |
| 9.5 | 82 | 360 | 179 | 261 | 237 | 0.1 | -4.3 | |
| -15 | 42 | -11 | 6.3 | -17 | -15 | 5.8 | 2.1 | |
| -24 | -39 | -88 | -160 | -166 | -208 | -171 | -125 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.